EUVIMEDEUVIMED entdecken
Crossref

Lymph node metastasis risk in submucosal invasive gastric cancer based on C-reactive protein gene polymorphism analysis

Kotaro Honda, Kohei Taniguchi, Kazumasa Komura, Tomohito Tanaka, Hidero Yoshimoto, Kentaro Matsuo, Yoshiro Imai, Ryo Tanaka, Mitsuaki Ishida, Yoshinobu Hirose, Satoru Motoyama, Sang-Woong Lee

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02884-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Kotaro Honda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Ja…. Hauptthemen laut MEDLINE: Stomach Neoplasms, C-Reactive Protein. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The 1846C > T polymorphism of the C-reactive protein (CRP) gene is associated with an increased risk of lymph node metastasis in various cancers. This study aimed to examine its association with lymph node metastasis in gastric cancer. METHODS: A retrospective analysis of the 1846C > T CRP polymorphism was conducted in patients with submucosal (SM) gastric cancer from April 2011 to March 2022. Genotyping was performed using polymerase chain reaction fragment length polymorphisms. Patients were categorized into differentiated and undifferentiated groups and then subdivided into C/C + C/T and T/T genotypes. We assessed correlations between polymorphisms, lymph node metastasis, and lymphatic and venous invasion. Two sub-analyses were conducted in the differentiated gastric cancer group. RESULTS: Among 111 patients with SM gastric cancer, 81 had differentiated tumors, whereas 30 had undifferentiated tumors. In the differentiated group, 4.5% of C/C and C/T genotypes and 18.9% of T/T genotypes exhibited lymph node metastasis, with a 95% negative predictive value. Excluding pT1b1 and tumors ≤ 3 cm, lymph node metastasis occurred in 5.3% of C/C and C/T genotypes and 20.6% of T/T genotypes, with a negative predictive value of 94.7%. For cT1bN0 cases, lymph node metastasis was 0% in C/C and C/T genotypes and 15.8% in T/T genotypes, with a negative predictive value of 100%. CONCLUSIONS: In this exploratory study, the 1846C > T CRP polymorphism suggests that patients with differentiated SM gastric cancer carrying the C/C or C/T genotype have reduced risk of lymph node metastasis, potentially minimizing the need for additional surgery after endoscopic submucosal dissection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsC-Reactive ProteinHumansMaleFemaleLymphatic MetastasisMiddle AgedRetrospective StudiesAgedGenotypePolymorphism, Single NucleotideAdultGenetic Predisposition to DiseaseNeoplasm InvasivenessRisk Factors

Stichwörter der Autor:innen

C-reactive proteinGastrectomyGastric cancerGenetic polymorphismLymph node metastasis

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
  • Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan. kohei.taniguchi@ompu.ac.jp.
  • Department of Urology, Kawasaki Medical School, 577 Matsushima, Kurashiki-City, , Okayama, 701-0192, Japan.
  • Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
  • Department of Pathology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
  • Department of Gastroenterological Surgery, Japanese Red Cross Akita Hospital, 222-1 Naeshirozawa, Saruta, Kamikitade, Akita-City, Akita, Japan.

Zitieren

APA

Honda, K., Taniguchi, K., Komura, K., Tanaka, T., Yoshimoto, H., Matsuo, K., Imai, Y., Tanaka, R., Ishida, M., Hirose, Y., Motoyama, S., & Lee, S. W. (2025). Lymph node metastasis risk in submucosal invasive gastric cancer based on C-reactive protein gene polymorphism analysis. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02884-1

Vancouver

Honda K, Taniguchi K, Komura K, Tanaka T, Yoshimoto H, Matsuo K, et al. Lymph node metastasis risk in submucosal invasive gastric cancer based on C-reactive protein gene polymorphism analysis. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02884-1

BibTeX
@article{Honda2025,
  author = {Honda, Kotaro and Taniguchi, Kohei and Komura, Kazumasa and Tanaka, Tomohito and Yoshimoto, Hidero and Matsuo, Kentaro and Imai, Yoshiro and Tanaka, Ryo and Ishida, Mitsuaki and Hirose, Yoshinobu and Motoyama, Satoru and Lee, Sang-Woong},
  title = {Lymph node metastasis risk in submucosal invasive gastric cancer based on C-reactive protein gene polymorphism analysis},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02884-1}
}
Kostenlos starten →